1gmy

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1gmy" size="450" color="white" frame="true" align="right" spinBox="true" caption="1gmy, resolution 1.9&Aring;" /> '''CATHEPSIN B COMPLEXE...)
Line 8: Line 8:
==About this Structure==
==About this Structure==
-
1GMY is a [[http://en.wikipedia.org/wiki/Single_protein Single protein]] structure of sequence from [[http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]] with APD, AEM, DFA, AEM and APD as [[http://en.wikipedia.org/wiki/ligands ligands]]. Active as [[http://en.wikipedia.org/wiki/ ]], with EC number [[http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.22.1 3.4.22.1]]. Full crystallographic information is available from [[http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1GMY OCA]].
+
1GMY is a [[http://en.wikipedia.org/wiki/Single_protein Single protein]] structure of sequence from [[http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]] with APD, AEM, DFA, AEM and APD as [[http://en.wikipedia.org/wiki/ligands ligands]]. Active as [[http://en.wikipedia.org/wiki/Cathepsin_B Cathepsin B]], with EC number [[http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.22.1 3.4.22.1]]. Structure known Active Site: ACT. Full crystallographic information is available from [[http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1GMY OCA]].
==Reference==
==Reference==
Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design., Greenspan PD, Clark KL, Tommasi RA, Cowen SD, McQuire LW, Farley DL, van Duzer JH, Goldberg RL, Zhou H, Du Z, Fitt JJ, Coppa DE, Fang Z, Macchia W, Zhu L, Capparelli MP, Goldstein R, Wigg AM, Doughty JR, Bohacek RS, Knap AK, J Med Chem. 2001 Dec 20;44(26):4524-34. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=11741472 11741472]
Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design., Greenspan PD, Clark KL, Tommasi RA, Cowen SD, McQuire LW, Farley DL, van Duzer JH, Goldberg RL, Zhou H, Du Z, Fitt JJ, Coppa DE, Fang Z, Macchia W, Zhu L, Capparelli MP, Goldstein R, Wigg AM, Doughty JR, Bohacek RS, Knap AK, J Med Chem. 2001 Dec 20;44(26):4524-34. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=11741472 11741472]
 +
[[Category: Cathepsin B]]
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
Line 44: Line 45:
[[Category: thiol protease]]
[[Category: thiol protease]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Oct 29 18:43:16 2007''
+
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Oct 30 12:02:07 2007''

Revision as of 09:57, 30 October 2007


1gmy, resolution 1.9Å

Drag the structure with the mouse to rotate

CATHEPSIN B COMPLEXED WITH DIPEPTIDYL NITRILE INHIBITOR

Overview

Cathepsin B is a member of the papain superfamily of cysteine proteases, and has been implicated in the pathology of numerous diseases, including, arthritis and cancer. As part of an effort to identify potent, reversible, inhibitors of this protease, we examined a series of dipeptidyl nitriles, starting with the previously reported Cbz-Phe-NH-CH(2)CN (19, IC(50) = 62, microM). High-resolution X-ray crystallographic data and molecular, modeling were used to optimize the P(1), P(2), and P(3) substituents of, this template. Cathepsin B is unique in its class in that it contains a, carboxylate recognition site in the S(2)' pocket of the active site., Inhibitor potency and selectivity were enhanced by tethering a carboxylate, functionality from the carbon alpha to the nitrile to interact with ... [(full description)]

About this Structure

1GMY is a [Single protein] structure of sequence from [Homo sapiens] with APD, AEM, DFA, AEM and APD as [ligands]. Active as [Cathepsin B], with EC number [3.4.22.1]. Structure known Active Site: ACT. Full crystallographic information is available from [OCA].

Reference

Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design., Greenspan PD, Clark KL, Tommasi RA, Cowen SD, McQuire LW, Farley DL, van Duzer JH, Goldberg RL, Zhou H, Du Z, Fitt JJ, Coppa DE, Fang Z, Macchia W, Zhu L, Capparelli MP, Goldstein R, Wigg AM, Doughty JR, Bohacek RS, Knap AK, J Med Chem. 2001 Dec 20;44(26):4524-34. PMID:11741472

Page seeded by OCA on Tue Oct 30 12:02:07 2007

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools